Record Display for the EPA National Library Catalog
RECORD NUMBER: 684 OF 1068Main Title | Proposed development document for new source performance standards for the pharmaceutical manufacturing point source category. | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CORP Author | Environmental Protection Agency, Washington, DC. Effluent Guidelines Div. | |||||||||||||||||||||||||||||||
Publisher | Effluent Guidelines Division, Office of Water, U.S. Environmental Protection Agency, | |||||||||||||||||||||||||||||||
Year Published | 1983 | |||||||||||||||||||||||||||||||
Report Number | EPA 440/1-83/084-b | |||||||||||||||||||||||||||||||
Stock Number | PB93-206969 | |||||||||||||||||||||||||||||||
OCLC Number | 10329168 | |||||||||||||||||||||||||||||||
Subjects | Effluent quality--United States ; Drug factories--Environmental aspects--United States ; Water pollution control industry--United States | |||||||||||||||||||||||||||||||
Additional Subjects | Drug industry ; Industrial waste treatment ; Chemical effluents ; Pollutions regulations ; Water pollution control ; Water pollution abatement ; Waste water ; Point sources ; Industrial plants ; Water pollution sampling ; Water pollution economics ; Economic impact ; Pretreatment ; Treatment technology ; BAT(Best Available Technology) | |||||||||||||||||||||||||||||||
Internet Access |
|
|||||||||||||||||||||||||||||||
Holdings |
|
|||||||||||||||||||||||||||||||
Collation | vii, 61 pages ; 28 cm | |||||||||||||||||||||||||||||||
Abstract | Pharmaceutical plants manufacture biological products, medicinal chemicals, botanical products, and other pharmaceutical products. EPA identified 466 operating facilities involved in the manufacture of pharmaceutical products. Most of the pharmaceutical industry is located in the eastern half of the United States. The most prevalent manufacturing operation in the industry is the formulating, mixing, and compounding operation; batch-type production is the most common type of manufacturing technique for this industry. The wastewaters produced and discharged by the pharmaceutical industry are very diverse. Plant size, products, processes, and materials to which wastewater is exposed vary greatly. Additionally, the ratio of finished product to the quantity of raw materials, solvents, and other processing materials is generally very low. |
|||||||||||||||||||||||||||||||
Notes | Cover title: Development document for effluent limitations guidelines and standards for the pharmaceuticals manufacturing. Distributed to depository libraries in microfiche. "September 1983." Includes bibliographical references. "EPA 440/1-83/084-b"--Cover. |